Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Apple
AAPL
|
+$975M |
| 2 |
Amazon
AMZN
|
+$708M |
| 3 |
UnitedHealth
UNH
|
+$634M |
| 4 |
Rivian
RIVN
|
+$504M |
| 5 |
TJX Companies
TJX
|
+$483M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.1B |
| 2 |
NVIDIA
NVDA
|
+$814M |
| 3 |
L3Harris
LHX
|
+$714M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$503M |
| 5 |
Texas Instruments
TXN
|
+$468M |
Sector Composition
| 1 | Technology | 32.52% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.42% |
| 4 | Financials | 9.67% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Scotiabank
BNS
$79.4B
| $41.9M | 0.02% |
591,005
+147,460
| +33% | +$10.5M |
|
602
Novanta
NOVT
$4.14B
| $41.7M | 0.02% |
236,629
+2,294
| +1% | +$404K |
|
603
Vontier
VNT
$6.29B
| $41.7M | 0.02% |
1,356,008
-427,277
| -24% | -$13.1M |
|
604
Republic Services
RSG
$71.3B
| $41.5M | 0.02% |
297,859
-184,515
| -38% | -$25.7M |
|
|
SAGE
605
DELISTED
Sage Therapeutics
SAGE
| $41.5M | 0.02% |
974,982
-76,011
| -7% | -$3.23M |
|
606
Synchrony
SYF
$27.8B
| $41.3M | 0.02% |
890,740
-2,311,409
| -72% | -$107M |
|
607
FB Financial Corp
FBK
$2.86B
| $41.3M | 0.02% |
942,460
-171,097
| -15% | -$7.5M |
|
|
VERV
608
DELISTED
Verve Therapeutics
VERV
| $41.2M | 0.02% |
1,162,796
+1,913
| +0.2% | +$67.8K |
|
609
Baker Hughes
BKR
$46.3B
| $41.1M | 0.02% |
1,707,108
+948,356
| +125% | +$22.8M |
|
|
BBL
610
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $40.9M | 0.02% |
684,322
+145,746
| +27% | +$8.71M |
|
|
DEN
611
DELISTED
Denbury Inc.
DEN
| $40.8M | 0.02% |
533,337
+528,293
| +10,474% | +$40.5M |
|
|
ICVX
612
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $40.8M | 0.02% |
+1,846,660
| New | +$40.8M |
|
613
Ventyx Biosciences
VTYX
$169M
| $40.8M | 0.02% |
+2,166,532
| New | +$40.8M |
|
614
Axalta
AXTA
$6.7B
| $40.7M | 0.02% |
1,229,194
+121,287
| +11% | +$4.02M |
|
615
O'Reilly Automotive
ORLY
$89.2B
| $40.6M | 0.02% |
862,635
-149,115
| -15% | -$7.02M |
|
616
Watts Water Technologies
WTS
$9.29B
| $40.6M | 0.02% |
208,861
-62,317
| -23% | -$12.1M |
|
|
FOCS
617
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $40.4M | 0.02% |
677,258
+154,764
| +30% | +$9.24M |
|
618
Zimmer Biomet
ZBH
$20.3B
| $40.4M | 0.02% |
327,817
+285,323
| +671% | +$35.2M |
|
619
MongoDB
MDB
$27.2B
| $40.4M | 0.02% |
76,292
+62,505
| +453% | +$33.1M |
|
|
DISCK
620
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $39.9M | 0.02% |
1,741,180
-97,346
| -5% | -$2.23M |
|
|
SILK
621
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $39.9M | 0.02% |
935,398
-14,676
| -2% | -$625K |
|
622
Ralph Lauren
RL
$18.9B
| $39.7M | 0.02% |
334,064
-3,085
| -0.9% | -$367K |
|
623
Toro Company
TTC
$7.68B
| $39.1M | 0.02% |
391,721
+298,740
| +321% | +$29.8M |
|
624
Clorox
CLX
$15.1B
| $38.8M | 0.02% |
222,731
-61,459
| -22% | -$10.7M |
|
625
Stride
LRN
$6.89B
| $38.8M | 0.02% |
1,163,057
+4,240
| +0.4% | +$141K |
|